Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy
Original Article
C. Touzeau, R. Mina, H. Quach, V. Hungria, D. Bhutani, W. Chen, S. Kumar, C. Chaulagain, M.A. Dimopoulos, N.J. Bahlis, S. Maral, N.W.v.d. Donk, J.S. Filho, K. Saja, R. Teipel, M. Ando, W. Roeloffzen, O. Annibali, B. Augustson, C. Botta, M. Delforge, E. Bourgeois, G. Buda, M. Hus, A. Perrot, M. Preis, M. Beksac, L. Pour, S. Farmer, M. Nunes, A. Oriol, T. Melchardt, Y. Hu, M. Flogegård, D. Wang, L. Pei, S. Wroblewski, I.M. Ariës, N.A.Q. Cardé, T. Perova, T.d. Jager, T.-M. Yeh, V. Vanquickelberghe, P. Shah, K. Chastain, R. Kobos, R. Carson, and O. Landgren
N Engl J Med 2026;395:440-453
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
07/29/2026
Course expires:
07/30/2028
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward